The company's earnings totaled $79.37 million, or $2.66 per share. This compares with $27.18 million, or $0.91 per share, last year. The company's revenue for the period rose 16.7% to $97.80 million ...
Few neighborhoods in Cambridge have seen their fortunes change as dramatically as Kendall Square. Kendall was once known for churning out soap and vulcanized rubber, then manufacturing electronics as ...
DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...
Oncolytics Biotech (NASDAQ:ONCY) has established a new at-the-market equity financing agreement with BTIG, LLC. As disclosed in a Securities and Exchange Commission (SEC) filing on October 17, 2025, ...
Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...
The use of B-cell–depleting antibodies for autoimmune disease has been well validated with significant use of Roche Holdings AG (OTC:RHHBY) and Biogen Inc (NASDAQ:BIIB) partnered Rituxan (rituximab) ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Hosted on MSN
Billionaires bet on AI, biotech: Here's what to know
CNBC's Robert Frank joins 'Squawk Box' with a look at where some of America's wealthiest individuals are putting their money. ‘Uncertain’: RBA takes air out of Trump deal King Charles arrives in Rome ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Founded in 2019, Enveda claimed ...
In case you've faced some hurdles solving the clue, Fictional biotech company in Severance, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...
Shares of UniQure N.V. rose 248% on Wednesday, lifted by a successful trial of the biotech’s gene therapy for Huntington’s disease, which has also boosted shares of partner ClearPoint Neuro Inc.
Twelve thousand international workers uphold Massachusetts’s booming technology and biotech industries — including more than 1,000 workers in Cambridge. But new fees on H-1B visas could soon cripple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback